Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25516127 | 1.00 | CNR2 (0.36) | CNR2SMN1; SMN2CYP24A1HTTLMNA | |
| SCHEMBL25516130 | 1.00 | CNR2 (0.36) | CNR2SMN1; SMN2CYP24A1HTTLMNA | |
| SCHEMBL25533461 | 0.86 | ALOX15 (0.35) | CNR2SMN1; SMN2CYP24A1HTTLMNA | |
| SCHEMBL25193264 | 0.82 | SMN1; SMN2 (0.49) | SMN1; SMN2HTTLMNAMAPTTP53 | |
| SCHEMBL25515343 | 0.82 | SMN1; SMN2 (0.49) | SMN1; SMN2HTTLMNAMAPTTP53 | |
| SCHEMBL25193261 | 0.82 | SMN1; SMN2 (0.49) | SMN1; SMN2HTTLMNAMAPTTP53 | |
| SCHEMBL30407572 | 0.80 | SMN1; SMN2 (0.43) | SMN1; SMN2HTTLMNAMAPTTP53 | |
| SCHEMBL7940402 | 0.76 | ALOX15 (0.46) | CNR2SMN1; SMN2CYP24A1HTTLMNA | |
| SCHEMBL7928980 | 0.76 | ALOX15 (0.46) | CNR2SMN1; SMN2CYP24A1HTTLMNA | |
| SCHEMBL7928983 | 0.76 | ALOX15 (0.46) | CNR2SMN1; SMN2CYP24A1HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150965-A1 | ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF | TERRAN BIOSCIENCES INC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150965-A1 | ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF | DBH, PNMT, MBTD1 | CNR2 497/4885SMN1; SMN2 54/4885CYP24A1 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.